Print

IAVI B003

A Phase 1 Placebo-controlled, Double-blind, Randomized Trial to Evaluate the Safety and Immunogenicity of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adult Volunteers

Trial Details:

I Completed
International AIDS Vaccine Initiative (IAVI), Beth Israel Deaconess Medical Center, Ragon Institute of MGH, MIT and Harvard, HIV Vaccine Trials Network October 04, 2010
Ad26.EnvA-01,Ad35-ENV Ad26 Env A; Ad35 Env A
Ad26.EnvA-01 Viral Vector - Adeno
Ad35-ENV Viral Vector - Adeno
Kenya, Rwanda, South Africa, USA 218
NCT01215149
http://clinicaltrials.gov/ct2/show/NCT01215149?term=hiv+vaccine&lup_s=09%2F06%2F2010&lup_d=30